Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform
Go back to Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform| Abbott Laboratories (NYSE: ABT) | Delayed: 90.53 +2.70 (3.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.83 | 52 Week High | $46.38 | |||
| Open | $88.95 | 52 Week Low | $36.00 | |||
| Day High | $90.93 | P/E | 60.35 | |||
| Day Low | $88.73 | EPS | $1.50 | |||
| Volume | 12,922,413 | |||||
